Litigation Details for Walgreen Co. v. Endo Health Solutions, Inc. (N.D. Ill. 2015)
✉ Email this page to a colleague
Walgreen Co. v. Endo Health Solutions, Inc. (N.D. Ill. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-03-26 |
Court | District Court, N.D. Illinois | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Harry Daniel Leinenweber |
Jury Demand | Plaintiff | Referred To | |
Patents | 7,276,250 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Walgreen Co. v. Endo Health Solutions, Inc.
Details for Walgreen Co. v. Endo Health Solutions, Inc. (N.D. Ill. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-03-26 | 1 | United States Patent No. 7,276,250 (the “‘250 patent”). The ‘143, ‘456, ‘933, and ‘250 patents are collectively…“‘143 patent”), United States Patent No. 5,958,456 (the “‘456 patent”) and United States Patent No. 5,662,933…, and ‘933 patents as well as any continuations of those patents and to any pending patent applications… risk (while the patent litigation was still pending); (b) after winning the patent litigation; or (c… the manufacturer’s patents for accuracy or trustworthiness. In listing patents in the Orange Book, | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |